Nalorex (Naltrexone Hydrochloride)

Naltrexone Hydrochloride, the active ingredient in Nalorex, is an opioid antagonist presented as an oral tablet for oral use. It is indicated for the treatment of alcohol dependence and for maintenance therapy in opioid‑dependent patients after detoxification.

GNH USA supplies Nalorex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for importers. Its global distribution network ensures efficient, timely delivery and compliance with local pharmacovigilance requirements.

Nalorex is used in the management of disorders related to alcohol and opioid use, acting on the central nervous system pathways that mediate dependence. - Alcohol dependence: reduces the reinforcing effects of alcohol, helping patients achieve and maintain abstinence when used as part of a comprehensive treatment program. - Opioid dependence (maintenance after detoxification): competitively blocks mu‑opioid receptors, preventing the euphoric effects of opioids and thereby reducing the risk of relapse in individuals who have completed detox. - Alcohol use disorder (relapse prevention): used as an adjunct to counseling and support services to sustain long‑term sobriety and lower the likelihood of heavy drinking episodes.

Naltrexone may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset, often transient. - Headache: dull or throbbing pain, may respond to analgesics. - Dizziness: sensation of light‑headedness, usually resolves with continued therapy. - Fatigue: feeling of tiredness or reduced energy levels.

Serious or Rare Side Effects: - Hepatotoxicity: significant increase in liver enzymes or clinical hepatitis. - Severe depression or suicidal thoughts: emergence of mood changes requiring immediate medical attention. - Allergic reactions: rash, itching, swelling, or anaphylactic response in rare cases.

When prescribing Nalorex, clinicians should consider several safety measures to minimize risks. - Assess liver function: obtain baseline hepatic enzymes before initiating therapy. - Monitor for depression: watch for mood changes or suicidal ideation throughout treatment. - Avoid in acute hepatitis: contraindicated in patients with active severe liver disease. - Use caution with opioid analgesics: may precipitate withdrawal if opioids are taken concurrently. - Educate patients on adherence: emphasize consistent daily dosing and avoidance of alcohol. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Nalorex can interact with several medicines; awareness of these interactions helps ensure safe use.

Major Interactions (Avoid): - Opioid agonists (e.g., morphine, oxycodone): can precipitate acute withdrawal. - Alcohol: concurrent use may increase hepatotoxic risk and reduce treatment efficacy. - Disulfiram: combined hepatotoxic potential warrants avoidance.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may enhance central nervous system effects; monitor mood. - Anticonvulsants (carbamazepine, phenytoin): can alter naltrexone metabolism; adjust dose if needed. - Rifampin or other enzyme inducers: may reduce plasma levels of naltrexone, decreasing effectiveness.